Announcement of setting up the Sustainable
Development Committee and members of TSH's first
Sustainable Development Committee
Date of events
2022/08/04
To which item it meets
paragraph 6
Statement
1.Date of occurrence of the change:2022/08/04
2.Name of the functional committees:Sustainable Development Committee
3.Name of the previous position holder:N/A
4.Resume of the previous position holder:N/A
5.Name of the new position holder:
(1)Yaw-Bin, Huang
(2)Chih-Li, Wang
(3)Rwei-Syun, Chen
6.Resume of the new position holder:
(1)Yaw-Bin, Huang/ Independent director
(2)Chih-Li, Wang/ Independent director
(3)Rwei-Syun, Chen/ Independent director
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):New appointment
8.Reason for the change: Establishment of the Sustainable Development
Committee
9.Original term (from __________ to __________):N/A
10.Effective date of the new member:2022/08/04
11.Any other matters that need to be specified:
(1)The term of office of the first Sustainable Development Committee is
the same as the Company's current Board of Directors.
(2)"Sustainable Development Committee Charter" was approved by TSH's Board
of Directors on August 4, 2022.
Attachments
Original Link
Original Document
Permalink
Disclaimer
TSH Biopharm Corporation Ltd. published this content on 04 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2022 09:26:01 UTC.
Tsh biopham corporation ltd. is a Taiwan-based company principally engaged in the manufacturing and distribution of medical preparations. The Company primarily provides medicines for cardiovascular, including Amtrel, Rytmonorm, Licodin, Isormol and ISOPTIN SR; medicines for intestines and stomach, including MOPRIDE, Catilon, Gastro-Timelet and Ribarin, and medicines for central nervous, including Aleviatin, Lonine and Lacoxa SR. The Company distributes its products mainly in domestic markets.